AstraZeneca PLC AZN announced its plans to lower 7,300 jobs to cut costs. It also projects a decline in its earnings this year.
AstraZeneca expects core earnings per share, excluding some items, between $6.00 and $6.30, versus $7.28 in 2011.
AstraZeneca's Q4 net profit dropped 8.3% to $1.49 billion, versus $1.62 billion, in the year-ago period, versus analysts' estimates of $1.68 billion. Its revenue came in at $8.66 billion, versus $8.62 billion, in the year-ago period, versus analysts' estimates of $8.56 billion.
AstraZeneca shares dropped 2.51% to $47.36 in pre-market trading.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in